Hot line:010-61006450
EN-
212021-12Warm Congratulations to the Chairman of Leadingpharm on being Elected Vice Chairman of the Committee of New Drug Creation and Development of Integrated Traditional Chinese and Western Medicine of Chinese Research Hospital Association
On December 18th, the establishment of the First Plenary Meeting of the New Drug Research and Development Committee of Integrated Chinese and Western Medicine was held in the Southern Club Hotel Guanghzou. Mr. Xinhua Tao, Chairman of Leadingpharm and Executive Director of China Research Hospital Association（CRHA）, was elected as the first vice chairman. -
142021-12Leadingpharm (Chongqing) Biomedical Integrated R & D Service Base Project was Officially Signed and Settled in Yongchuan
On December 10, the project of Leadingpharm (Chongqing) Biomedical Integrated R & D Service Base was officially signed and settled. Leadingpharm will work together with Yongchuan to build a biomedical industry cluster with national influence. -
092021-12New Progress of Research | the Clinical Trial Project of the World's First Stem Cell Innovative Drug for Ulcerative Colitis Start in the Affiliated Hospital of Qingdao University
Recently, the clinical test project of Human Umbilical Cord Mesenchymal Stem Cell Injection studied by the scientific research team of Qingdao Allcare Biomedical Development(ABMO) for patients with moderate and severe ulcerative colitis initiated a clinical trial in the Affiliated Hospital of Qingdao University, and subjects are recruited to the whole regions. -
072021-12Leadingpharm Strategic Cooperated with China Certification & Inspection （Group）., Ltd, Looking for In-depth Co-Development in Medical Analysis and Testing
On December 7, 2021, Leadingpharm and China Certification & Inspection （Group）Co . , Ltd .（CCIC） signed a strategic cooperation agreement. The two sides will give full play to their respective resources and technical advantages, conduct in-depth cooperation in the field of pharmaceutical analysis and testing, and jointly build a public service platform for testing and evaluation of health product. -
272021-11Leadingpharm and Huluwa Work Together to Jointly Build a High-end Pediatric Drug R&D Platform
Recently, Leadingpharm and Huluwa Pharmaceutical Group signed a memorandum of strategic cooperation, and the two sides reached a cooperation intention on the construction of a high-end pediatric drug research institute.
010-61006450
Address：
Marketing Department：
Leadingpharm
Pharm News
010-61006450
